Angiogenesis inhibitors for metastatic colorectal cancer

被引：3
|
作者：
Pfeiffer, Per [1 ,2 ,4 ]
Liposits, Gabor [2 ,3 ]
Taarpgaard, Line Schmidt [1 ,2 ]
机构：
[1] Odense Univ Hosp, Dept Oncol, Odense, Denmark
[2] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[3] Godstrup Hosp, Dept Oncol, Herning, Denmark
[4] Odense Univ Hosp, Dept Oncol, Sdr Blvd 29, DK-5000 Odense, Denmark
来源：
TRANSLATIONAL CANCER RESEARCH | 2023年 / 12卷 / 12期
关键词：
Colorectal cancer (CRC); angiogenesis inhibitors; fruquintinib; BEVACIZUMAB; PLACEBO; FRUQUINTINIB; MULTICENTER; EFFICACY; TAS-102;
D O I：
10.21037/tcr-23-1568
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3241 / 3244
页数：4
相关论文
共 50 条
  • [1] Unraveling the Complexities of Treating Metastatic Colorectal Cancer With Angiogenesis Inhibitors
    Overstreet, Karen
    Van Cutsem, Eric
    Johnson, Monique
    CLINICAL COLORECTAL CANCER, 2015, 14 (03) : 131 - 132
  • [2] Angiogenesis inhibitors and symptomatic anal ulcers in metastatic colorectal cancer patients
    Bergamo, Francesca
    Lonardi, Sara
    Salmaso, Beatrice
    Lacognata, Carmelo
    Battaglin, Francesca
    Cavallin, Francesco
    Saadeh, Luca
    Murgioni, Sabina
    Caruso, Antonino
    Aliberti, Camillo
    Zagonel, Vittorina
    Castoro, Carlo
    Scarpa, Marco
    ACTA ONCOLOGICA, 2018, 57 (03) : 412 - 419
  • [3] Angiogenesis inhibitors in the treatment of colorectal cancer
    Iqbal, S
    Lenz, HJ
    SEMINARS IN ONCOLOGY, 2004, 31 (06) : 10 - 16
  • [4] Visualising and quantifying angiogenesis in metastatic colorectal cancer
    Hansen, Torben Frostrup
    Nielsen, Boye Schnack
    Jakobsen, Anders
    Sorensen, Flemming Brandt
    CELLULAR ONCOLOGY, 2013, 36 (04) : 341 - 350
  • [5] Angiogenesis-inhibitors for metastatic thyroid cancer
    Tan, Aihua
    Xia, Ning
    Gao, Feng
    Mo, Zengnan
    Cao, Yunfei
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (03):
  • [6] The Value and Effectiveness of Angiogenesis Inhibitors for Colorectal Cancer
    Venook, Alan P.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (09) : 561 - 563
  • [7] Pathological responses after angiogenesis or EGFR inhibitors in metastatic colorectal cancer depend on the chemotherapy backbone
    J Carrasco
    M Gizzi
    G Pairet
    V Lannoy
    P Lefesvre
    J-F Gigot
    C Hubert
    A Jouret-Mourin
    Y Humblet
    J-L Canon
    C Sempoux
    X Chapaux
    E Danse
    N Tinton
    B Navez
    M Van den Eynde
    British Journal of Cancer, 2015, 113 : 1298 - 1304
  • [8] Pathological responses after angiogenesis or EGFR inhibitors in metastatic colorectal cancer depend on the chemotherapy backbone
    Carrasco, J.
    Gizzi, M.
    Pairet, G.
    Lannoy, V.
    Lefesvre, P.
    Gigot, J-F
    Hubert, C.
    Jouret-Mourin, A.
    Humblet, Y.
    Canon, J-L
    Sempoux, C.
    Chapaux, X.
    Danse, E.
    Tinton, N.
    Navez, B.
    Van den Eynde, M.
    BRITISH JOURNAL OF CANCER, 2015, 113 (09) : 1298 - 1304
  • [9] Angiogenesis inhibition in metastatic colorectal cancer continuum of care
    Martinelli, Erika
    Ciardiello, Fortunato
    LANCET, 2023, 402 (10395): : 4 - 5
  • [10] Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
    Weijing Sun
    Journal of Hematology & Oncology, 5
12345